Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2023

Open Access 01-12-2023 | Coronary Heart Disease | Research

Associations of circulating fatty acids with incident coronary heart disease: a prospective study of 89,242 individuals in UK Biobank

Authors: Danyao Jin, Eirini Trichia, Nazrul Islam, Sarah Lewington, Ben Lacey

Published in: BMC Cardiovascular Disorders | Issue 1/2023

Login to get access

Abstract

Background

The role of fatty acids in coronary heart disease (CHD) remains uncertain. There is little evidence from large-scale epidemiological studies on the relevance of circulating fatty acids levels to CHD risk. This study aims to examine the independent associations of the major circulating types of fatty acids with CHD risk.

Methods

UK Biobank is a prospective study of adults aged 40–69 in 2006–2010; in 2012–2013, a subset of the participants were resurveyed. Analyses were restricted to 89,242 participants with baseline plasma fatty acids (measured using nuclear magnetic resonance spectroscopy) and without prior CHD. Cox proportional hazards models were used to estimate hazard ratios (HRs) for the associations with incidence CHD, defined as the first-ever myocardial infarction, unstable angina pectoris, coronary-related death, or relevant procedure. And the major types of fatty acids were mutually adjusted to examine the independent associations. Hazard ratios were corrected for regression dilution using the correlation of baseline and resurvey fatty acids measures.

Results

During a median follow-up of 11.8 years, 3,815 incident cases of CHD occurred. Independently of other fatty acids, CHD risk was positively associated with saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA), inversely associated with omega-3 polyunsaturated fatty acids (PUFA), but there was no strong evidence of an association with omega-6 PUFA: HR per standard deviation higher were 1.14 (95% CI, 1.09–1.20), 1.15 (1.10–1.21), 0.91 (0.87–0.94), and 1.04 (0.99–1.09) respectively. Independently of triglycerides and cholesterol, the inverse association with omega-3 PUFA was not materially changed, but the positive associations with SFA and MUFA attenuated to null after adjusting for triglycerides levels.

Conclusions

This large-scale study has quantitated the independent associations of circulating fatty acids with CHD risk. Omega-3 PUFA was inversely related to CHD risk, independently of other fatty acids and major lipid fractions. By contrast, independently of other fatty acids, the positive associations of circulating SFA and MUFA with CHD risk were mostly attributed to their relationship with triglycerides.
Appendix
Available only for authorised users
Literature
1.
go back to reference Organization WH. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. Volume 916. World Health Organization; 2003. Organization WH. Diet, nutrition, and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. Volume 916. World Health Organization; 2003.
2.
go back to reference Piepoli MF, Hoes AW, Agewall S, et al. 2016 european guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81.CrossRefPubMedPubMedCentral Piepoli MF, Hoes AW, Agewall S, et al. 2016 european guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81.CrossRefPubMedPubMedCentral
3.
go back to reference Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary Fats and Cardiovascular Disease: a Presidential Advisory from the American Heart Association. Circulation. 2017;136(3):e1–e23.CrossRefPubMed Sacks FM, Lichtenstein AH, Wu JHY, et al. Dietary Fats and Cardiovascular Disease: a Presidential Advisory from the American Heart Association. Circulation. 2017;136(3):e1–e23.CrossRefPubMed
4.
go back to reference Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5(5):Cd011737.PubMed Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5(5):Cd011737.PubMed
5.
go back to reference Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3):e1000252.CrossRefPubMedPubMedCentral Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3):e1000252.CrossRefPubMedPubMedCentral
6.
go back to reference Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707.CrossRefPubMedPubMedCentral Ramsden CE, Zamora D, Leelarthaepin B, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013;346:e8707.CrossRefPubMedPubMedCentral
7.
go back to reference Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary experiment (1968-73). BMJ. 2016;353:i1246.CrossRefPubMedPubMedCentral Ramsden CE, Zamora D, Majchrzak-Hong S, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary experiment (1968-73). BMJ. 2016;353:i1246.CrossRefPubMedPubMedCentral
8.
go back to reference Tvrzicka E, Kremmyda LS, Stankova B, Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease–a review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):117–30.CrossRefPubMed Tvrzicka E, Kremmyda LS, Stankova B, Zak A. Fatty acids as biocompounds: their role in human metabolism, health and disease–a review. Part 1: classification, dietary sources and biological functions. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):117–30.CrossRefPubMed
9.
go back to reference Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr. 2005;25:317–40.CrossRefPubMed Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu Rev Nutr. 2005;25:317–40.CrossRefPubMed
10.
go back to reference Weinberg RL, Brook RD, Rubenfire M, Eagle KA. Cardiovascular Impact of Nutritional Supplementation with Omega-3 fatty acids: JACC Focus Seminar. J Am Coll Cardiol. 2021;77(5):593–608.CrossRefPubMed Weinberg RL, Brook RD, Rubenfire M, Eagle KA. Cardiovascular Impact of Nutritional Supplementation with Omega-3 fatty acids: JACC Focus Seminar. J Am Coll Cardiol. 2021;77(5):593–608.CrossRefPubMed
11.
go back to reference Clarke R, Emberson JR, Breeze E, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J. 2008;29(6):800–9.CrossRefPubMed Clarke R, Emberson JR, Breeze E, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J. 2008;29(6):800–9.CrossRefPubMed
12.
go back to reference Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341–53.CrossRefPubMed Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341–53.CrossRefPubMed
13.
go back to reference Borges MC, Schmidt AF, Jefferis B, et al. Circulating fatty acids and risk of Coronary Heart Disease and Stroke: individual Participant Data Meta-Analysis in Up to 16 126 participants. J Am Heart Assoc. 2020;9(5):e013131.CrossRefPubMedPubMedCentral Borges MC, Schmidt AF, Jefferis B, et al. Circulating fatty acids and risk of Coronary Heart Disease and Stroke: individual Participant Data Meta-Analysis in Up to 16 126 participants. J Am Heart Assoc. 2020;9(5):e013131.CrossRefPubMedPubMedCentral
14.
go back to reference Del Gobbo LC, Imamura F, Aslibekyan S, et al. ω-3 polyunsaturated fatty acid biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med. 2016;176(8):1155–66.CrossRefPubMedPubMedCentral Del Gobbo LC, Imamura F, Aslibekyan S, et al. ω-3 polyunsaturated fatty acid biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies. JAMA Intern Med. 2016;176(8):1155–66.CrossRefPubMedPubMedCentral
16.
go back to reference Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.CrossRefPubMedPubMedCentral Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.CrossRefPubMedPubMedCentral
17.
go back to reference Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circulation Cardiovasc Genet. 2015;8(1):192–206.CrossRef Soininen P, Kangas AJ, Würtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circulation Cardiovasc Genet. 2015;8(1):192–206.CrossRef
18.
go back to reference Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic Technologies. Am J Epidemiol. 2017;186(9):1084–96.CrossRefPubMedPubMedCentral Würtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -Omic Technologies. Am J Epidemiol. 2017;186(9):1084–96.CrossRefPubMedPubMedCentral
20.
go back to reference Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348–80.CrossRefPubMed Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348–80.CrossRefPubMed
21.
go back to reference Health NCf H, Do, Centre SCI. OPCS classifications of interventions and procedures. Volume 1. The Stationery Office; 2006. Health NCf H, Do, Centre SCI. OPCS classifications of interventions and procedures. Volume 1. The Stationery Office; 2006.
23.
go back to reference Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10(7):1025–35.CrossRefPubMed Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10(7):1025–35.CrossRefPubMed
24.
25.
go back to reference Marklund M, Wu JHY, Imamura F, et al. Biomarkers of Dietary Omega-6 fatty acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019;139(21):2422–36.CrossRefPubMedPubMedCentral Marklund M, Wu JHY, Imamura F, et al. Biomarkers of Dietary Omega-6 fatty acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019;139(21):2422–36.CrossRefPubMedPubMedCentral
26.
go back to reference Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398–406.CrossRefPubMed Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160(6):398–406.CrossRefPubMed
27.
go back to reference Würtz P, Havulinna AS, Soininen P, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774–85.CrossRefPubMedPubMedCentral Würtz P, Havulinna AS, Soininen P, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774–85.CrossRefPubMedPubMedCentral
28.
go back to reference Garaulet M, Pérez-Llamas F, Pérez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74(5):585–91.CrossRefPubMed Garaulet M, Pérez-Llamas F, Pérez-Ayala M, et al. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr. 2001;74(5):585–91.CrossRefPubMed
29.
go back to reference Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568–78.CrossRefPubMedPubMedCentral Farvid MS, Ding M, Pan A, et al. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation. 2014;130(18):1568–78.CrossRefPubMedPubMedCentral
30.
go back to reference Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425–32.CrossRefPubMedPubMedCentral Jakobsen MU, O’Reilly EJ, Heitmann BL, et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009;89(5):1425–32.CrossRefPubMedPubMedCentral
31.
go back to reference Fats. and fatty acids in human nutrition. Report of an expert consultation. FAO Food Nutr Pap. 2010;91:1-166. Fats. and fatty acids in human nutrition. Report of an expert consultation. FAO Food Nutr Pap. 2010;91:1-166.
32.
go back to reference Rimm EB, Appel LJ, Chiuve SE, et al. Seafood Long-Chain n-3 polyunsaturated fatty acids and Cardiovascular Disease: A Science Advisory from the American Heart Association. Circulation. 2018;138(1):e35–e47.CrossRefPubMedPubMedCentral Rimm EB, Appel LJ, Chiuve SE, et al. Seafood Long-Chain n-3 polyunsaturated fatty acids and Cardiovascular Disease: A Science Advisory from the American Heart Association. Circulation. 2018;138(1):e35–e47.CrossRefPubMedPubMedCentral
33.
go back to reference Hu Y, Hu FB, Manson JE. Marine Omega-3 Supplementation and Cardiovascular Disease: an updated Meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc. 2019;8(19):e013543.CrossRefPubMedPubMedCentral Hu Y, Hu FB, Manson JE. Marine Omega-3 Supplementation and Cardiovascular Disease: an updated Meta-analysis of 13 randomized controlled trials involving 127 477 participants. J Am Heart Assoc. 2019;8(19):e013543.CrossRefPubMedPubMedCentral
34.
go back to reference Aung T, Halsey J, Kromhout D, et al. Associations of Omega-3 fatty acid supplement Use with Cardiovascular Disease Risks: Meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol. 2018;3(3):225–34.CrossRefPubMed Aung T, Halsey J, Kromhout D, et al. Associations of Omega-3 fatty acid supplement Use with Cardiovascular Disease Risks: Meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol. 2018;3(3):225–34.CrossRefPubMed
35.
go back to reference Nicholls SJ, Lincoff AM, Garcia M, et al. Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse Cardiovascular events in patients at High Cardiovascular Risk: the STRENGTH Randomized Clinical Trial. JAMA. 2020;324(22):2268–80.CrossRefPubMedPubMedCentral Nicholls SJ, Lincoff AM, Garcia M, et al. Effect of high-dose Omega-3 fatty acids vs corn oil on major adverse Cardiovascular events in patients at High Cardiovascular Risk: the STRENGTH Randomized Clinical Trial. JAMA. 2020;324(22):2268–80.CrossRefPubMedPubMedCentral
36.
go back to reference Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22.CrossRefPubMed Bhatt DL, Steg PG, Miller M, et al. Cardiovascular Risk reduction with Icosapent Ethyl for Hypertriglyceridemia. N Engl J Med. 2019;380(1):11–22.CrossRefPubMed
37.
go back to reference Bowman L, Mafham M, Wallendszus K, et al. Effects of n-3 fatty acid supplements in diabetes Mellitus. N Engl J Med. 2018;379(16):1540–50.CrossRefPubMed Bowman L, Mafham M, Wallendszus K, et al. Effects of n-3 fatty acid supplements in diabetes Mellitus. N Engl J Med. 2018;379(16):1540–50.CrossRefPubMed
38.
go back to reference Kalstad AA, Myhre PL, Laake K, et al. Effects of n-3 fatty acid supplements in Elderly Patients after myocardial infarction: a Randomized, Controlled Trial. Circulation. 2021;143(6):528–39.CrossRefPubMed Kalstad AA, Myhre PL, Laake K, et al. Effects of n-3 fatty acid supplements in Elderly Patients after myocardial infarction: a Randomized, Controlled Trial. Circulation. 2021;143(6):528–39.CrossRefPubMed
39.
go back to reference Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2019;380(1):23–32.CrossRefPubMed Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and Prevention of Cardiovascular Disease and Cancer. N Engl J Med. 2019;380(1):23–32.CrossRefPubMed
40.
go back to reference Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (London England). 2007;369(9567):1090–8.CrossRefPubMed Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (London England). 2007;369(9567):1090–8.CrossRefPubMed
41.
go back to reference Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011;70(2):215–31.CrossRefPubMed Cottin SC, Sanders TA, Hall WL. The differential effects of EPA and DHA on cardiovascular risk factors. Proc Nutr Soc. 2011;70(2):215–31.CrossRefPubMed
42.
go back to reference Nishizaki Y, Miyauchi K, Iwata H, et al. Study protocol and baseline characteristics of Randomized trial for evaluation in secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study. Am Heart J. 2023;257:1–8.CrossRefPubMed Nishizaki Y, Miyauchi K, Iwata H, et al. Study protocol and baseline characteristics of Randomized trial for evaluation in secondary Prevention Efficacy of Combination Therapy-Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of a randomized control trial and an observational biomarker study. Am Heart J. 2023;257:1–8.CrossRefPubMed
43.
go back to reference Borges MC, Haycock PC, Zheng J, et al. Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants. BMC Med. 2022;20(1):210.CrossRefPubMedPubMedCentral Borges MC, Haycock PC, Zheng J, et al. Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants. BMC Med. 2022;20(1):210.CrossRefPubMedPubMedCentral
44.
go back to reference Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–67.CrossRefPubMed Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58(20):2047–67.CrossRefPubMed
45.
go back to reference Li-Gao R, Hughes DA, le Cessie S, et al. Assessment of reproducibility and biological variability of fasting and postprandial plasma metabolite concentrations using 1H NMR spectroscopy. PLoS ONE. 2019;14(6):e0218549.CrossRefPubMedPubMedCentral Li-Gao R, Hughes DA, le Cessie S, et al. Assessment of reproducibility and biological variability of fasting and postprandial plasma metabolite concentrations using 1H NMR spectroscopy. PLoS ONE. 2019;14(6):e0218549.CrossRefPubMedPubMedCentral
Metadata
Title
Associations of circulating fatty acids with incident coronary heart disease: a prospective study of 89,242 individuals in UK Biobank
Authors
Danyao Jin
Eirini Trichia
Nazrul Islam
Sarah Lewington
Ben Lacey
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2023
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-023-03394-6

Other articles of this Issue 1/2023

BMC Cardiovascular Disorders 1/2023 Go to the issue